Sudair Pharma Showcases Innovative Pharmaceutical Solutions at CPHI Milan 2024
Sudair Pharma participated in CPHI Milan 2024 as part of the Saudi Made pavilion, showcasing advanced pharmaceutical solutions and reaffirming its commitment to innovation and localization in the Kingdom’s healthcare sector.
Sudair Pharma Participates in National Agreement with Sanofi and NUPCO to Localize Insulin Production in Saudi Arabia
Sudair Pharma is proud to be part of a national agreement with Sanofi and NUPCO to localize insulin production in Saudi Arabia, supporting pharmaceutical security and strengthening the Kingdom’s position as a regional center for healthcare innovation.
Sudair Pharma Highlighted in the National Local Content Report for Its Advancements in Pharmaceutical Localization
Sudair Pharma was featured in the sixth edition of the National Local Content Report, highlighting its progress in localizing pharmaceutical products and contributing to national economic development.
Sudair Pharma Showcases Major Local Content Achievements at the Local Content Forum 2024
Sudair Pharma participated prominently in the Local Content Forum 2024, announcing the launch of its “Ghrs Program” for local content development, showcasing strategic achievements, and taking part in key panel discussions, workshops, and exhibitions. The company reaffirmed its commitment to strengthening national pharmaceutical security and advancing local innovation in alignment with Saudi Vision 2030.
Sudair Pharma Achieves “Saudi Made” Golden Tier Classification
Sudair Pharma has been awarded the prestigious Saudi Made Golden Tier classification, recognizing the company’s exceptional contribution to national localization efforts, investment in Saudi talent, and utilization of locally sourced materials in pharmaceutical manufacturing.
Saudi Minister of Health Visits Sudair Pharma to Review Advanced Pharmaceutical Facilities and Strengthen National Drug Security
Sudair Pharma welcomed His Excellency the Minister of Health for an official visit to review the company’s advanced manufacturing facilities and pharmaceutical technologies. The visit also included a symbolic palm-tree planting ceremony and highlighted Sudair Pharma’s pivotal role in strengthening national drug security and supporting Vision 2030 objectives.
Minister of Industry and Mineral Resources Lays Foundation Stone for Sudair Pharma’s Insulin Manufacturing Facility
Sudair Pharma was honored to welcome His Excellency the Minister of Industry and Mineral Resources during a special visit to lay the foundation stone for the company’s new insulin manufacturing facility—an important step in strengthening pharmaceutical localization and meeting national healthcare needs.
Sudair Pharma CEO Participates in Saudi–US Investment Forum to Discuss the Future of Healthcare Innovation
Sudair Pharma’s CEO Dr. Yasser Alobaidaa participated in the Saudi–US Investment Forum to discuss innovation in health technologies and the importance of global partnerships in shaping the future of healthcare.
Sudair Pharma Showcases Advanced Pharmaceutical Capabilities at the Saudi Industry Forum 2025
Sudair Pharma participated in the Saudi Industry Forum 2025, highlighting its leadership in pharmaceutical localization, innovation, and national drug security. The company showcased its work in cancer therapies, insulin production, and advanced manufacturing technologies in alignment with Saudi Vision 2030.
Sudair Pharma Strengthens Cardiovascular Health Efforts with Active Participation and Strategic Collaboration at the Saudi Heart Association Conference
Sudair Pharma participated in the Saudi Heart Association Conference, showcasing its commitment to cardiovascular health through scientific engagement, community awareness, and a strategic MoU with the Saudi Heart Association to advance joint efforts in education and treatment.